Qualigen Therapeutics Inc
F:7R9B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Q
|
Qualigen Therapeutics Inc
F:7R9B
|
US |
|
R
|
Raiffeisen Bank International AG
F:RAW
|
AT |
Dividends
Dividend Yield
Qualigen Therapeutics Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Qualigen Therapeutics Inc
7R9B have decreased by 0%.
Payout Ratio
Qualigen Therapeutics Inc
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
7R9B is
.
Peers Comparison
Shareholder Yield
Price Appreciation
7R9B Price
Qualigen Therapeutics Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -93% |
| Market Capitalization | 4.7m EUR |
| Shares Outstanding | 38 795 541 |
| Percentage of Shares Shorted |
N/A
|
7R9B Return Decomposition
Main factors of price return
Stock Splits
7R9B's latest stock split occurred on May 26, 2020
The company executed a 1-for-25 stock split, meaning that for every 25 shares held, investors received 1 new share.
Before the split, 7R9B traded at 0.436 per share. Afterward, the share price was about 7.021.
The adjusted shares began trading on May 26, 2020. This was the only stock split in 7R9B's history.